ev3 plans buy-out of Micro Therapeutics
This article was originally published in Clinica
ev3, the Plymouth, Minnesota-based developer of endovascular technologies, has proposed to buy all the remaining shares of its partially-owned subsidiary Micro Therapeutics.
You may also be interested in...
The German Bundestag has adopted the Unified Patent Court’s draft ratification bill with the necessary qualified majority.
UK-based charity International Health Partners has launched a fresh appeal to double the value funds being raised to send essential medicines to expectant mothers and children at risk of death in areas of extreme deprivation.
As the first emergency use authorization is granted, Pfizer and Moderna stand accused of neglecting poorer nations as wealthy countries snap up early access to COVID-19 vaccines.